Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):11-5. doi: 10.1016/j.pnpbp.2008.08.023. Epub 2008 Nov 5.

Abstract

Risperidone has demonstrated therapeutic advantages over conventional neuroleptics and offers a valuable emerging option for the treatment of social behavior associated with autistic disorder. Considering the putative involvement of astroglial cells in neuropsychiatric disorders, we investigated the effect of risperidone on parameters of astrocyte activity - glutamate uptake, glutamine synthetase (GS) activity and glutathione (GSH) levels. Risperidone was able to induce a significantly increase on glutamate uptake (32%); GS activity (15%); GSH levels (58%). These findings imply the perspectives for further investigations directed on astrocytes from different brain areas. Our present results suggest that risperidone might exert its neuroprotective effects against brain illness at least partially via modulation of astrocyte functions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antipsychotic Agents / pharmacology*
  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • Cell Line, Tumor
  • Cells, Cultured
  • Glutamate-Ammonia Ligase / metabolism
  • Glutamic Acid / metabolism
  • Glutathione / metabolism
  • Nitric Oxide / metabolism
  • Rats
  • Reactive Oxygen Species / metabolism
  • Risperidone / pharmacology*
  • Thiobarbituric Acid Reactive Substances / metabolism

Substances

  • Antipsychotic Agents
  • Reactive Oxygen Species
  • Thiobarbituric Acid Reactive Substances
  • Nitric Oxide
  • Glutamic Acid
  • Glutamate-Ammonia Ligase
  • Glutathione
  • Risperidone